Clinical trial
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
NCT05052853 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
- Lead sponsor
- China Medical University Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- November 1, 2021
- Completion date
- December 31, 2026
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prodromal schizophrenia